Article Listing - Chugai gets expanded indications for natulan

EC "BLOW" TO NEW OTC PRODUCTS

10 February 1992

As it now stands, the Commission of the European Communities' proposed directive on advertising of over-the counter products in the...

"KEY" US PATENT FOR BIOPURE'S HEMOPURE

10 February 1992

Boston, Massachusetts-based start-up company Biopure Corp reports that it has received a US patent covering its novel blood substitute Hemopure,...

PFIZER PLANS NEW UNIT IN USA

10 February 1992

US pharmaceutical concern Pfizer is setting up a new unit at its Groton plant in the USA.The company has...

END OF FRENCH BLOC ON NEW DRUG INTROS

3 February 1992

The French government has agreed to renew the commission which gives advice to the Health Minister on drug-price fixing for...

RU's DIMETROSE FOR CYCLIC MASTALGIA

3 February 1992

A multicenter study investigating the applicability and safety of Roussel Uclaf's Dimetrose (gestrinone) as a treatment for women with cyclical...

WYETH AYERST/ TLC FLU VACCINE DEAL

3 February 1992

Wyeth-Ayerst Laboratories, a division of American Home Products, has entered into an agreement with The Liposome Company concerning the development...

ROBERTS' SOMAGARD APPROVED IN EIRE

3 February 1992

Roberts Pharmaceutical Corporation has been granted marketing approval by the Republic of Ireland's regulatory authorities for its prostate cancer treatment...

STOCK MARKET COMMENTARY: TOKYO

3 February 1992

TOKYO: closed with a 0.4% gain at 21,007.11 yen after a volatile trading week dominated by index and futures- linked...

STOCK MARKET COMMENTARY: EUROPE

3 February 1992

EUROPE: saw ups and downs on the reporting week, with Belgium, Germany and Switzerland the strongest stock markets. FRANKFURT saw...

DU PONT'S JOHN KROL

3 February 1992

- John Krol has been named as a vice chairman and director of Du Pont Co.

Showing 94841-94850 of 95337 articles

Go to beginningPreviousNextGo to end